RevenueNet IncomeP/EP/SEBITDividendStocksMarket capitalizationDebtLiabilitiesEquityAAQSEmployeesROEROAROCE
Level Biotechnology Stock

Level Biotechnology Liabilities 2024

Level Biotechnology Liabilities

273.2 M TWD

Ticker

3118.TWO

ISIN

TW0003118006

In 2024, Level Biotechnology's total liabilities amounted to 273.2 M TWD, a 1.14% difference from the 270.13 M TWD total liabilities in the previous year.

Level Biotechnology Aktienanalyse

What does Level Biotechnology do?

Level Biotechnology ist eines der beliebtesten Unternehmen auf Eulerpool.com.

Liabilities Details

Assessing Level Biotechnology's Liabilities

Level Biotechnology's liabilities constitute the company's financial obligations and debts owed to external parties and stakeholders. They are categorized into current liabilities, due within a year, and long-term liabilities, which are due over a longer period. A detailed assessment of these liabilities is crucial for evaluating Level Biotechnology's financial stability, operational efficiency, and long-term viability.

Year-to-Year Comparison

By comparing Level Biotechnology's liabilities year-over-year, investors can identify trends, shifts, and anomalies in the company’s financial positioning. A decrease in total liabilities often signals financial strengthening, while an increase might indicate enhanced investments, acquisitions, or potential financial strain.

Impact on Investments

Level Biotechnology's total liabilities play a significant role in determining the company's leverage and risk profile. Investors and analysts examine this aspect meticulously to ascertain the firm’s ability to meet its financial obligations, which influences investment attractiveness and credit ratings.

Interpreting Liability Fluctuations

Shifts in Level Biotechnology’s liability structure indicate changes in its financial management and strategy. A reduction in liabilities reflects efficient financial management or debt payoffs, while an increase may suggest expansion, acquisition activities, or accruing operational expenses, each carrying distinct implications for investors.

Frequently Asked Questions about Level Biotechnology stock

What is the level of liabilities of Level Biotechnology this year?

Level Biotechnology has a debt balance of 273.2 M TWD this year.

What were the liabilities of Level Biotechnology compared to the previous year?

The liabilities of Level Biotechnology have increased by 1.14% increased compared to the previous year.

What are the consequences of high debt for investors of Level Biotechnology?

High liabilities can pose a risk for investors of Level Biotechnology, as they can weaken the company's financial position and impair its ability to meet its obligations.

What consequences do low liabilities have for investors in Level Biotechnology?

Low liabilities mean that Level Biotechnology has a strong financial position and is able to meet its obligations without overburdening its finances.

How does an increase in liabilities of Level Biotechnology affect the company?

An increase in liabilities of Level Biotechnology can lead to the company having more obligations and potentially find it more difficult to meet its financial commitments.

How does a reduction in the liabilities of Level Biotechnology affect the company?

A decrease in the liabilities of Level Biotechnology can lead to the company having fewer obligations and a stronger financial position, which can make it easier for the company to fulfill its financial commitments.

What are some factors that influence the liabilities of Level Biotechnology?

Some factors that can influence the liabilities of Level Biotechnology include investments, acquisitions, operating costs, and sales development.

Why is the level of liabilities of Level Biotechnology so important for investors?

The liabilities of Level Biotechnology are important for investors as they serve as an indicator of the company's financial stability and provide investors with information on how the company meets its financial obligations.

What strategic measures can Level Biotechnology take to modify the liabilities?

To change its liabilities, Level Biotechnology can take measures such as cost savings, increasing revenue, selling assets, raising investments, or forming partnerships. It is important for the company to conduct a thorough review of its financial situation to choose the best strategic actions.

How much dividend does Level Biotechnology pay?

Over the past 12 months, Level Biotechnology paid a dividend of 1.7 TWD . This corresponds to a dividend yield of about 5.24 %. For the coming 12 months, Level Biotechnology is expected to pay a dividend of 1.7 TWD.

What is the dividend yield of Level Biotechnology?

The current dividend yield of Level Biotechnology is 5.24 %.

When does Level Biotechnology pay dividends?

Level Biotechnology pays a quarterly dividend. This is distributed in the months of .

How secure is the dividend of Level Biotechnology?

Level Biotechnology paid dividends every year for the past 2 years.

What is the dividend of Level Biotechnology?

For the upcoming 12 months, dividends amounting to 1.7 TWD are expected. This corresponds to a dividend yield of 5.24 %.

In which sector is Level Biotechnology located?

Level Biotechnology is assigned to the 'Health' sector.

Wann musste ich die Aktien von Level Biotechnology kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Level Biotechnology from 7/12/2024 amounting to 1.7 TWD, you needed to have the stock in your portfolio before the ex-date on 6/18/2024.

When did Level Biotechnology pay the last dividend?

The last dividend was paid out on 7/12/2024.

What was the dividend of Level Biotechnology in the year 2023?

In the year 2023, Level Biotechnology distributed 1.9 TWD as dividends.

In which currency does Level Biotechnology pay out the dividend?

The dividends of Level Biotechnology are distributed in TWD.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

Andere Kennzahlen von Level Biotechnology

Our stock analysis for Level Biotechnology Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Level Biotechnology Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.